Validic integrates with Smart Meter cellular-enabled connected health devices

Validic Inc., a market-leading digital health and personalized care company, continues to expand its healthcare IoT platform with the integration of Smart Meter. This integration brings exclusive cellular-enabled, patient-friendly monitoring devices supplied by Smart Meter, a leading connected health solution supplier to a rapidly growing nationwide network of SmartPartners, to the Validic ecosystem.

"Our proprietary monitoring devices can only connect and transmit patient-generated data when connected to our private data network, ensuring reliable and secure delivery to Validic clients," said Smart Meter Chief Marketing Officer Bill Bassett. "And eliminating the need for patients to pair, sync or connect to Wi-Fi or an app on their phone may improve patient satisfaction and increase the use of their monitoring devices."

Validic's health IoT platform is the largest ecosystem of connected health devices and apps, which streams continuous, near-real-time personal health data from 540+ home health and wearable devices. Organizations can access blood pressure, pulse oxygen, blood glucose, heart rate, weight, temperature, sleep, nutrition, respiratory, activity data, and more through a single, endpoint connection.

"Technology should be so easy to use that it becomes invisible to the person using it," said Validic CEO Drew Schiller. "The addition of Smart Meter cellular-enabled health monitoring devices to our ecosystem offers another option to help people focus on their health and live their best lives."

Validic clients can request the addition of Smart Meter connected health devices to their marketplace by submitting a request to support@validic.com.

About Smart Meter, LLC
Smart Meter is the number one trusted supplier of cellular remote patient Monitoring (RPM) solutions. We empower a nationwide network of SmartPartnersTM who are working directly with healthcare providers to transform patient care. Millions of vital health data readings are reliably delivered across our platform to enable real-time, better-informed health care. Our proprietary patient-friendly, cellular FDA-registered monitoring devices are connected to an exclusive AT&T 4/5G network to ensure an engaging patient experience for improved adherence. For more information, visit SmartMeterRPM.com

About Validic
Founded in 2010, Validic Inc. is a digital health and personalized care company devoted to our mission of improving the quality of human life by making personal data actionable. With the world's largest health IoT platform and EHR-embedded remote care application, we help healthcare organizations give every person tailored interventions and personalized care, improving healthcare efficiency and delivery, and empowering people to play an active role in their health and well-being.

Leading healthcare providers, health plans and health IT companies, such as Mass General Brigham, Cleveland Clinic, Mayo Clinic, CVS Health and Elevance Health, use our solutions to deliver high-touch and personalized chronic condition management, remote care, and support for healthy living. With a platform intentionally built to support a broad digital health strategy and scale across populations and conditions, Validic supports the largest RPM program in the country, with more than 300,000 enrolled patients since its inception and 7,000 referring providers. Our digital health platform has 540+ supported devices with more than 15 billion annual data transactions. Our remote care solution is available as a standard integration in the Epic Connection Hub and Cerner Millennium®.

In 2022, Validic received the North American Customer Value Award for the Medical Device Connectivity Industry by Frost and Sullivan and was named Best Overall Connected Healthcare Solution by MedTech Breakthrough. Validic is HIPAA-compliant, HITRUST CSF Certified®, and ISO-27001 certified for Information Security Management. Visit Validic.com and follow @Validic on Twitter and LinkedIN to learn more.

133 Million Breached Patient Records in 2023 Builds Demand for Reliable Healthcare Technology Partners

The alarming surge in HIPAA breaches persists, with a staggering increase from 51.9 million patient records compromised in 2022 to 133 million in 2023, marking a 256% rise.1 Faced with this relentless onslaught, healthcare providers are intensifying their internal and vendor security measures.

Smart Meter, a premier supplier of cellular remote patient monitoring solutions supporting numerous healthcare programs nationwide, continues to surpass expectations in reliability and security. In 2023, the company's SOC 2 compliant platform managed 1.93 billion records, delivering patient-generated vital signs to healthcare managers. The Remote Patient Monitoring (RPM) platform achieved an impressive 6 years of 100% uptime, supporting an average delivery time of 86 milliseconds.

A core principle in handling patient-generated health data is an unwavering commitment to safeguarding patient health information. The potential risks associated with placing patient data in a vulnerable position—subject to theft, modification, or misuse—require careful consideration by healthcare providers, particularly in their choice of RPM solution vendors. Hacking incidents constituted 79.72% of all significant data breaches in 2023.2 Vendor systems must provide an integrated layered security model that connects patient devices to the RPM platform, effectively mitigating these cyber threats.

“Smart Meter is the trusted industry leader in RPM, blending cutting-edge technology with user-friendly solutions that propel success for our customers,” emphasized Bill Bassett, Chief Marketing Officer at Smart Meter. “The unparalleled scale and reliability of our purpose-built RPM Private Data Network, complimented with our proprietary Cellular RPM™ devices ensures prompt delivery of patient-generated vital signs.”

In a strategic collaboration with AT&T, Smart Meter has invested significantly in data security technology. This investment plays a crucial role in ensuring the continuous protection and security of patient data, providing a robust defense against potential HIPAA breaches. Smart Meter's commitment to integrating advanced technology, user-friendly solutions, and robust security measures underscores their dedication to delivering reliable and secure RPM services to healthcare providers and, ultimately, improving, and stabilizing patient outcomes.

About Smart Meter, LLC

Smart Meter is the trusted supplier of Remote Patient Monitoring (“RPM”) solutions. We empower a nationwide network of SmartPartnersTM who are working directly with healthcare providers to transform patient care. Millions of vital health data readings are reliably delivered across our platform to enable real-time, better-informed health care. Our proprietary patient-friendly cellular FDA-registered monitoring devices are connected to an exclusive AT&T 4/5G network to ensure an engaging patient experience for improved adherence. For more information, visit SmartMeterRPM.com

1- December 2023 Healthcare Data Breach Report (hipaajournal.com)

2- December 2023 Healthcare Data Breach Report (hipaajournal.com)

Smart Meter CEO Appointed To AT&T Healthcare Executive Advisory Council

Smart Meter, the number one supplier of cellular remote patient monitoring devices and data, is pleased to announce that its CEO, Casey Pittock, has been appointed to the AT&T Healthcare Executive Advisory Council (HEAC). The HEAC is comprised of leaders from healthcare enterprise firms who are at the C Suite level of their organization and responsible for setting global networking strategy priorities. The council collaborates as a group to guide AT&T’s senior executives on global business and healthcare topics of mutual strategic interest.

“Being appointed to the AT&T HEAC is a prestigious honor for Smart Meter and reflects the importance of monitoring people’s health remotely with cellular technology,” Pittock said. “Smart Meter works exclusively with AT&T because of their leadership in healthcare telecommunications and impeccable reputation, and our relationship continues to expand, enabling us to provide fast, reliable, and secure vital sign data so healthcare professionals can make better-informed care decisions.”

The HEAC plays an integral role in helping to shape AT&T’s strategy for developing products and services. Feedback from the HEAC may influence investment priorities and key marketing initiatives, enabling AT&T to refine its business direction to align with its clients’ business challenges and opportunities more directly. Council members also have a unique opportunity for peer-to-peer networking, sharing best practices, and gaining knowledge on leading-edge technology strategies.

“Smart Meter is one of the most innovative and fastest growing companies we work with,” said Joe Drygas, VP of AT&T Government, Education, and Healthcare. “We are pleased to have Smart Meter join our Healthcare Executive Advisory Council. Their leadership in cellular remote monitoring will bring added value to the Council.”

Before joining Smart Meter, Pittock was the founder and CEO of Udex Software, a cloud platform for the home health industry. Previously, he was President and CEO of Tunstall Americas, the US division of Tunstall Healthcare Group, the world’s largest medical alarm provider. He served as CEO at two health tech start-ups and led sales at BAM Labs, the technology powering smart beds. Pittock was also the founder and CEO of TelCARE Systems, which was acquired by Lifeline, and subsequently by Philips Electronics North America. Over a twenty-five year career the products and services his companies delivered have helped millions of people better manage their health.

About Smart Meter, LLC

Smart Meter is the trusted supplier of Remote Patient Monitoring (“RPM”) solutions. We empower a nationwide network of SmartPartnersTM who are working directly with healthcare providers to transform patient care. Millions of vital health data readings are reliably delivered across our platform to enable real-time, better-informed health care. Our proprietary patient-friendly cellular FDA-registered monitoring devices are connected to an exclusive AT&T 4/5G network to ensure an engaging patient experience for improved adherence. For more information, visit SmartMeterRPM.com

Smart Meter Builds on Role as Innovator in Cellular Remote Patient Monitoring

New patents awarded for cellular-enabled RPM™ in the US and Europe

Smart Meter, the leading provider of cellular Remote Patient Monitoring (RPM) solutions, has recently been granted two groundbreaking patents, expanding its position as a healthcare technology innovator. The integration of cellular connectivity into vital sign monitoring devices for more reliable and effective remote patient monitoring traces back to Benjamin Atkin, a successful serial entrepreneur and founder of Smart Meter. After being diagnosed with diabetes, Atkin quickly grew frustrated with trying to manage his condition with unreliable Bluetooth® glucose meters. He set out to build the world's first cellular-enabled glucose meter and in 2017 received approval from the FDA for the iGlucose® cellular-enabled glucose meter. In 2019, he was granted the related patent for the wireless monitoring of medical test data. Since then, Smart Meter has expanded its intellectual property portfolio, and the latest patents secured by the company build upon this rich legacy of innovation.

Smart Meter has been granted a patent by the United States Patent and Trademark Office for a cellular pulse oximeter system This cutting-edge, cellular-connected system for collecting pulse oximetry data, revolutionizes the interaction with end-users. Patients simply attach the pulse oximeter to their finger, press one button, and after collecting physiologic data, the pulse oximetry system seamlessly transmits information to healthcare providers through Smart Meter’s Private Data Network for RPM built with AT&T. The system modernizes pulse oximetry with features like multi-user capability, voice-controlled interaction, and audio-visual indicators. With the potential to simplify chronic condition management for over 54 million Americans, including those with COPD, heart disease, and post-COVID complications, Smart Meter’s patented solution for pulse oximetry technology, will help healthcare professionals monitor health and reduce costs.

Smart Meter has also been granted a patent by the European Patent Office, titled "System, Apparatus, and Method for the Wireless Monitoring of Medical Test Data,". This patent complements the earlier United States patent awarded to Atkin for the iGlucose cellular glucose meter system, presenting a comprehensive approach for various medical tests. The European patent includes the automatic transmission of aggregated physiologic data results through European cellular networks, enabling wireless transmission, storage, monitoring, notifications, and additional functionalities. This innovative method supports the management of chronic conditions, including diabetes, underlining Smart Meter's commitment to advancing global wireless monitoring solutions for medical test data.

“Innovation is one of the five strategic pillars at Smart Meter and our product development team works at the forefront of new technologies, systems, and processes to facilitate care management for our national network of cellular RPM customers,” said Casey Pittock, CEO of Smart Meter. “We will continue to supply the remote patient monitoring industry with meaningful, technology-driven solutions that deliver relevant data to support better care.”

About Smart Meter, LLC
Smart Meter is the trusted supplier of Remote Patient Monitoring (“RPM”) solutions. We empower a nationwide network of SmartPartnersTM who are working directly with healthcare providers to transform patient care. Millions of vital health data readings are reliably delivered across our platform to enable real-time, better-informed health care. Our proprietary patient-friendly cellular FDA-registered monitoring devices are connected to an exclusive AT&T 4/5G network to ensure an engaging patient experience for improved adherence. For more information, visit SmartMeterRPM.com

 

Research Provides Proof That Cellular RPM™ Is Easy To Use And Can Improve Outcomes

Three recent patient research reports show that cellular remote patient monitoring™(RPM) programs are an effective way for patients to become more involved with their care between visits to their healthcare provider. Patients find using cellular RPM monitors very easy and convenient when measuring their vital signs, leading to better outcomes. Healthcare providers benefit from securely and automatically receiving those vital sign readings, helping them monitor and manage patient care between office visits.

In a 30-day study by the University of Arkansas for Medical Sciences, 59 pregnant women with Type 1 or Type 2 diabetes, who frequently tested with Smart Meter’s cellular-enabled iGlucose® glucometer showed an increased satisfaction with their diabetes management. Eighty-six percent of participants noted that the automatic transmission of blood glucose results to their physician helped them better maintain their condition. Participants who used the iGlucose glucose meter demonstrated increased positive appraisal of diabetes and general life satisfaction. In addition, participants scored the cellular RPM™ iGlucose device high for both system usability and satisfaction. The overall feedback on the iGlucose glucose meter, the gold standard since receiving FDA approval in 2016, was positive across multiple evaluation points.

Baum Consulting Services implemented an RPM program using Smart Meter’s cellular devices and saw excellent results. One of the highlights of the program included a male patient in his 70s with hypertension, who, after two out-of-range blood pressure readings had adjustments made to his medication was able to avoid an emergency room visit. Another patient with diabetes had an A1c of 10.4 before starting the program but was able to reduce that to 6.6 in about a year and a half.

Results from both the 2023 National Hypertension Survey and the 2023 National Diabetes Survey indicated that a majority of patients would test more consistently knowing their readings were automatically sent to their provider. In addition, 59 percent of hypertension patients and 70 percent of diabetes patients said they believe an RPM program would help them better manage their disease.

“This research is part of a growing body of evidence that remote monitoring of patients is a valuable tool for stabilizing and improving healthcare outcomes. Cellular RPM solutions continue to add value to patient care management because patients find them significantly more straightforward to use, leading to improved patient engagement in their health between office visits,” said Bill Bassett, Chief Marketing Officer for Smart Meter. “Providers benefit from the secure, real-time transmission of patient vital signs, empowering them with the information to support improved decision making and expediting time to intervention.”

Smart Meter has all the resources needed for healthcare professionals to implement a cellular RPM program, including a free guide on how to get started. The guide provides insights into the history of cellular RPM technology, the benefits of RPM (including reimbursement opportunities through the Centers for Medicare and Medicaid), why cellular RPM is better than Bluetooth®, and a simple plan for developing an RPM program. The guide can be downloaded by going to this page.

About Smart Meter, LLC

Smart Meter is the trusted supplier of Remote Patient Monitoring (“RPM”) solutions. We empower a nationwide network of SmartPartnersTM who are working directly with healthcare providers to transform patient care. Millions of vital health data readings are reliably delivered across our platform to enable real-time, better-informed health care. Our proprietary patient-friendly cellular FDA-registered monitoring devices are connected to an exclusive AT&T 4/5G network to ensure an engaging patient experience for improved adherence. For more information, visit SmartMeterRPM.com

Expanded Program Benefits 62 Million Vulnerable Americans With Limited Access To Healthcare

Cellular remote patient monitoringTM will be a reimbursable care service for Federally Qualified Health Centers and Rural Health Clinics in 2024

The final rule of the 2024 Medicare Physician Fee Schedule from the Centers for Medicare and Medicaid (CMS) was recently released and includes expanded support for some of the most vulnerable and underserved Americans living in rural and urban communities with limited access to healthcare. One of the most impactful changes is that Federally Qualified Health Centers (FQHCs) and Rural Health Clinics (RHCs), which care for many of these Americans, can add remote patient monitoring (RPM) to their care management services as a reimbursable program. Starting January 1, 2024, FQHCs and RHCs will be eligible to bill for RPM under the general care management code G0511.

There are more than 15,000 FQHCs and RHCs in the country, serving over 62 million patients who have limited access to healthcare due to economic or geographic circumstances. Many of these vulnerable and underserved Americans suffer from chronic diseases, including hypertension and diabetes, and may have difficulty accessing healthcare services. Remote patient monitoring is proving to be an extremely useful service, especially cellular RPMTM, when managing care for chronic condition patients.

In the 2023 National Diabetes Survey, 51 percent of respondents said they only see their healthcare professional twice a year or less and 86 percent said their physician recommends changes to their care plan based on their readings when they see them. But most of the time healthcare providers are making care plan decisions based on limited data, with some research suggesting that glucose logs are inaccurate or falsified up to 50 percent of the time.1 Using cellular RPMTM diabetes management would change that by transmitting a reading immediately to the provider’s electronic health record (EHR) system for tracking and review.

Sixty-two percent of participants in the survey said they would test more consistently knowing their results were being sent to their provider. And in the 2023 National Hypertension Survey, 53 percent said they would test more frequently if they knew their readings were being sent to their provider. In addition, 59 percent of hypertension patients and 70 percent of diabetes patients said they believe an RPM program would help them better manage their disease.

Healthcare professionals with FQHCs or RHCs who start using cellular RPM in 2024 would be providing their patients with an easy method for testing and ensuring the reading is transmitted immediately to the provider for review. And with the new CMS final rule, the FQHC or RHC would be reimbursed for collecting this data.

Patients are looking for easy ways for providers to help them improve their chronic conditions at home. With cellular-enabled RPM solutions from Smart Meter, providers are assured of getting the latest and most accurate data when a patient tests. This can help identify trends, prevent hospitalization, and improve outcomes.

“Patients who are served by FQHCs or RHCs typically have issues making regular visits to the clinics and have limited Wi-Fi access for Bluetooth® RPM devices. It is much easier for a patient to use a cellular-enabled monitor because there is no synching, pairing or Wi-Fi needed,” said Dr. Bill Lewis, a member of the ClearHealth Quality Institute (CHQI) Telemedicine Standards and Medical Advisory Board and Chair of the Telemedicine Accreditation Committee. “Smart Meter’s iGlucose® meters, iBloodPressure® monitors, and other cellular RPM solutions transmit instantly through an exclusive AT&T private data network, so data is secure, accurate, and reliable every time.”

About Smart Meter, LLC

Smart Meter is the trusted supplier of Cellular Remote Patient MonitoringTM (“RPM”) solutions. We empower a nationwide network of SmartPartnersTM who are working directly with healthcare providers to transform patient care. Millions of vital health data readings are reliably delivered across our platform to enable real-time, better-informed health care. Our proprietary patient-friendly cellular FDA-registered monitoring devices are connected to an exclusive AT&T 4/5G network to ensure an engaging patient experience for improved adherence. For more information, visit SmartMeterRPM.com

1 Doctors Want To See Your Glucose Meter | Prevention

 

Seventy Percent of People With Diabetes Have Issues Transmitting Their Reading Using Bluetooth® Remote Patient Monitoring Devices

The results of the 2023 National Diabetes Care Survey, a longitudinal analysis of patients with Type 2 diabetes in the United States, have been released and provide important insights into how remote patient monitoring (RPM) can benefit patients with chronic conditions. The survey results show that Cellular RPM programs are easier for patients to use than those using Bluetooth®-enabled devices, with 70% of participants who use a Bluetooth device indicating they sometimes, often, or always have issues sending their readings to their provider, and the majority (56%) of that group saying they always have issues.

For the same question in the 2022 National Diabetes Care Survey, 60% of those surveyed responded they had an issue, indicating a 10% jump in the number of people with issues. So while there was an increase in respondents indicating they use a Bluetooth-enabled glucose monitor in this year’s survey, there was also an increase in the number of people who have issues with pairing, synching, and Wi-Fi in order for the reading to be transmitted to a healthcare professional for tracking glucose levels.

Approximately 33 million Americans have Type 2 diabetes, but according to one study, about 45% of them don’t adequately control their glucose levels.1 Testing their glucose and knowing their reading on a regular basis can help people with Type 2 diabetes better manage their disease. It is also imperative for their physician to know their daily glucose reading to provide guidance and possible adjustments to their care plan.

With most people with Type 2 diabetes only seeing their doctor two times a year or less, they are asked to keep track of their testing numbers for long periods of time. If a patient is solely responsible for writing down their readings for review by their physician during an office visit, there may be an issue with those readings. It is estimated that 50% of patients don’t adequately track readings or provide false readings to their doctor.2

“While Bluetooth-connected devices for monitoring people with diabetes are common, they are not always the most effective,” said Dr. Bill Lewis, a member of the CHQI Telemedicine Standards and Medical Advisory Board and Chair of the Telemedicine Accreditation Committee. “Connection issues with Bluetooth devices are a common problem and patients become less likely to utilize the technology. A device that utilizes an automatic cellular transmission of data resolves so many of these problems for people with diabetes.”

Patients and providers are looking for an easy-to-use glucometer so glucose readings can be taken at home and transmitted to a healthcare professional. With cellular-enabled remote glucose monitoring solutions from Smart Meter, providers are assured of getting the latest and most accurate data when a patient tests. This can help identify trends, prevent hospitalization, and improve outcomes between office visits.

Cellular-enabled monitors are some of the easiest for patients to use to test their glucose levels regularly at home. The convenience of cellular-based glucose monitors enables better patient adherence to care plan instructions, leading to stabilized or better control of diabetes.

“When patients use a cellular-enabled glucose meter, they know their results are being sent immediately to their provider,” Lewis said. “Smart Meter’s iGlucose and new iGlucose Essential glucose meters transmit instantly through an exclusive AT&T private data network so data is secure, accurate, and reliable every time.”

You can view the complete results of the 2023 National Diabetes Care Survey here.

About Smart Meter, LLC

Smart Meter is the trusted supplier of Remote Patient Monitoring (“RPM”) solutions. We empower a nationwide network of SmartPartnersTM who are working directly with healthcare providers to transform patient care. Millions of vital health data readings are reliably delivered across our platform to enable real-time, better-informed health care. Our proprietary patient-friendly cellular FDA-registered monitoring devices are connected to an exclusive AT&T 4/5G network to ensure an engaging patient experience for improved adherence. For more information, visit SmartMeterRPM.com

1 Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors - PMC (nih.gov)

2 Doctors Want To See Your Glucose Meter | Prevention

iGlucose® Cellular RPM™ Shown Efficacious for Managing Diabetes Mellitus During Pregnancy

UAMS research finds that the Smart Meter cellular-enabled glucose meter ensures optimal health outcomes for the 366,000 mothers with Type 1 and Type 2 diabetes during pregnancy

A recently published research study from the University of Arkansas for Medical Sciences concluded that using cellular-enabled RPM™ glucose meters is valuable in managing Type 1 diabetes mellitus and Type 2 diabetes mellitus during pregnancy. Participants who used the iGlucose® glucose meter demonstrated increased positive appraisal of diabetes and general life satisfaction. In addition, participants scored the cellular RPM™ iGlucose® device high on both system usability and satisfaction. The overall feedback on the iGlucose® glucose meter, the gold standard in cellular RPM™ glucose meters since receiving FDA approval in 2016, was positive across multiple evaluation points.

Cellular RPM™ programs are proving to be an effective way for patients to measure vital signs quickly and easily, like blood glucose levels. Physicians benefit from automatically receiving those vital signs, helping them monitor and manage patient care between office visits. In a 30-day study of 59 pregnant women with Type 1 or Type 2 diabetes, those who frequently tested with their iGlucose® glucose showed an increase in satisfaction with their diabetes management.

Eighty-six percent of participants noted that the automatic transmission of blood glucose results to their physician helped them better maintain their condition. Additionally, all participants indicated positive outcomes with system usability and a positive experience using iGlucose and Cellular RPM™ technology overall.

Participants cited many benefits of using the cellular-enabled RPM solution, including

“The research conducted by UAMS provides an excellent view into the value that cellular-enabled remote physiologic monitoring delivers to physicians and all health care providers,” stated Bill Bassett, Chief Marketing Officer, Smart Meter, LLC. “The results reflected that patients feel like they have more control of their health, are receiving better care, and are more satisfied using our proprietary monitoring devices.”

About 1 in every 9 adult women are diagnosed with diabetes in the US, with 8.3% of pregnant mothers having a gestational diabetes diagnosis during pregnancy.1,2 Women with Type 1 and Type 2 Diabetes Mellitus during pregnancy require frequent glucose monitoring, and the need to test glucose levels four to six times per day can be challenging. Regular testing is easier and more efficient utilizing cellular RPM™ to deliver the results to the patient and their health care provider without needing to log them. This automated data delivery ensures peace of mind and stability for the patient’s diabetes care plan. You can access the published findings using this link.

 About Smart Meter, LLC

Smart Meter is the trusted supplier of Remote Patient Monitoring (“RPM”) solutions. We empower a nationwide network of SmartPartnersTM who are working directly with healthcare providers to transform patient care. Millions of vital health data readings are reliably delivered across our platform to enable real-time, better-informed health care. Our proprietary patient-friendly cellular FDA-registered monitoring devices are connected to an exclusive AT&T 4/5G network to ensure an engaging patient experience for improved adherence. For more information, visit SmartMeterRPM.com

 

Seventy-One Percent of Persons With Type 2 Diabetes Say a Remote Patient Monitoring (RPM) Program Would Help Them Better Manage Their Health

The results of the Diabetes Care Survey, a longitudinal analysis of patients with Type 2 diabetes in the United States, have been released for 2023 and provide important insights into how remote patient monitoring (RPM) can benefit patients with chronic conditions. The survey results show that Cellular RPM programs are proving to be an effective and efficient way for physicians to follow the progress of a patient’s health, with 71% of participants indicating that using remote patient monitoring would help them better manage their condition between office visits.

For the same question in the 2021 Diabetes Care Survey, only 35 percent of the respondents indicated that an RPM program would better help them manage their diabetes. The dramatic increase shows a rise in the awareness, ease of use, and effectiveness of a cellular remote glucose monitoring program.

Approximately 33 million Americans have Type 2 diabetes, but according to one study, about 45 percent of them don’t adequately control their glucose levels.1 Testing their glucose and knowing their reading on a regular basis can help people with Type 2 diabetes, and their physicians, better manage their disease.

Cellular-enabled monitors are some of the easiest for patients to use to test their glucose levels regularly at home. The convenience of cellular-based glucose monitors enables better patient adherence to care plan instructions, leading to stabilized or improved outcomes.

In the Diabetes Care Survey, 62% of participants said they would test more consistently knowing their results were being sent to their provider. With most people with Type 2 diabetes only seeing their doctor two times a year or less, they are asked to keep track of their testing numbers for long periods of time. If the patient is solely responsible for writing down their readings for review by their physician during an office visit, there may be an issue with those readings.

Patients are looking for easy ways for providers to help them improve their diabetes at home. With cellular-enabled remote glucose monitoring solutions from Smart Meter, providers are assured of getting the latest and most accurate data when a patient tests. This can help identify trends, prevent hospitalization, and improve outcomes.

“When patients use a cellular-enabled glucose meter, they know their results are being sent immediately to their provider,” said Dr. Bill Lewis, a member of the ClearHealth Quality Institute (CHQI) Telemedicine Standards and Medical Advisory Board and Chair of the Telemedicine Accreditation Committee. “Smart Meter’s iGlucose transmits instantly through an exclusive AT&T private data network so data is secure, accurate, and reliable every time.”

You can view the complete results of the Diabetes Care Survey here.

About Smart Meter, LLC

Smart Meter is the trusted supplier of Remote Patient Monitoring (“RPM”) solutions. We empower a nationwide network of SmartPartnersTM who are working directly with healthcare providers to transform patient care. Millions of vital health data readings are reliably delivered across our platform to enable real-time, better-informed health care. Our proprietary patient-friendly cellular FDA-registered monitoring devices are connected to an exclusive AT&T 4/5G network to ensure an engaging patient experience for improved adherence. For more information, visit SmartMeterRPM.com

 1 Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors - PMC (nih.gov)

PharmD Live And Smart Meter Team Up For 455 Pharmacist Interventions To Help Improve Patient Outcomes

PharmD Live, a pharmacist-led chronic care management (CCM) and medication management program, was founded to improve clinical outcomes and reduce adverse effects due to drug interactions. While PharmD Live has a robust medication management program that is overseen by clinical pharmacists, it has grown to offer so much more than that with the help of Smart Meter’s cellular-enabled remote patient monitoring devices and data.

The PharmD Live team works across multiple disease states and chronic conditions, with a wide range of patient populations, especially geriatric patients, and patients on Medicare and Medicaid. They take a hands-on approach to patient care and work to not only improve health outcomes but also to educate and inspire patients to take on a more empowered role in their health and wellbeing.

“When you compare a patient seeing their PCP (Primary Care Physician) for 15 minutes every six months to spending an hour with a clinical pharmacist every month, you can start to see what a significant impact that plays on their health outcomes”, said Dr. Nwaubani. “We work very closely with their physicians so that there is continuity of care, and they [physicians] have all of the data they need to be able to make informed care decisions and interventions.”

It was this commitment to streamlining the care process, and using data to arm physicians with the clinical intelligence they need to better manage their patients’ chronic diseases that led the team at PharmD Live to Smart Meter cellular-enabled devices. Using Smart Meter’s easy-to-use, one-step medical devices, patient-generated health data is transmitted securely, reliably, and in real-time to a provider.

This offers their patients an effortless way to adhere to their care plans. That, coupled with Smart Meter’s device and logistics management tools and programs, allows PharmD Live to spend more time with their patients and grow their business.

This patient-first approach to care and clinical oversight resulted in 455 pharmacist interventions between July 1, 2022 and January 31, 2023. These are interventions that likely would not have occurred in a traditional care delivery model, or without the expertise of a pharmacist reviewing patient health data.

To read more about PharmD Live’s commitment to improved patient outcomes and successes, please go to Smart Meter’s SmartPartners’ Success Stories page.

About Smart Meter, LLC

Smart Meter is the number one supplier of Remote Patient Monitoring ("RPM") solutions to a nationwide network of SmartPartners™ who are transforming patient care and today are used by over 230,000 patients in the US. Millions of vital health data readings are reliably delivered across our secure platform, enabling SmartPartners to provide real-time, better-informed health care. Our proprietary, patient-friendly, cellular, FDA-approved monitoring devices are connected to an exclusive AT&T IoT Private Data Network to ensure an engaging patient experience for improved adherence. For more information, visit SmartMeterRPM.com.